Cathay Biotech Inc. (SHA:688065)

Revenue by Product

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Long Chain Dibasic Acid	2.67B
Long Chain Dibasic Acid Growth	39.94%
Bio-based Polyamide	144.31M
Bio-based Polyamide Growth	-6.44%
Other Business	138.84M
Other Business Growth	194.33%
Other	4.93M
Other Growth	-0.00%
Other	4.93M
Other Growth	-0.00%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
China	1.86B
China Growth	35.75%
Overseas	955.08M
Overseas Growth	37.63%